Participant timeline
Participants will be enrolled at the time of their first visit to the buprenorphine treatment provider. Participants will be seen up to four times in Stage 1 randomization at their next four provider visits. Assessments and intervention will occur at each of these visits. If a participant is re-randomized into Stage 2, they will be seen at the next four visits. Assessments and intervention will also occur at each of these visits. There will be a final follow-up assessment 8 months after enrollment.